Key Record Dates
ClinicalTrials.gov Identifier: | NCT01886872 |
---|---|
Brief Title: | Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia |
First Submitted : | June 24, 2013 |
First Submitted that Met QC Criteria : | June 24, 2013 |
First Posted : | June 26, 2013 (Estimate) |
Results First Submitted : | September 30, 2019 |
Results First Submitted that Met QC Criteria : | December 10, 2019 |
Results First Posted : | December 30, 2019 |
Last Update Submitted that Met QC Criteria : | April 3, 2024 |
Last Update Posted : | April 4, 2024 |